Prior authorization — the process where a health plan must approve certain services or treatments before you receive them — has long been a source of frustration for Medicare beneficiaries and providers alike. In 2026, significant federal reforms are reshaping how prior authorization works across Medicare Advantage, Part D, and even Original Medicare for the first time. These changes aim to speed up decisions, increase transparency, and reduce unnecessary delays in care.
Here is what you should know about the new rules, how they may affect your coverage, and what rights you have if a prior authorization request is denied.
What Is Prior Authorization and Why Does It Matter?
Prior authorization (sometimes called "prior approval" or "pre-certification") is a requirement that your health plan approve a medical service, procedure, prescription drug, or piece of equipment before you receive it. The plan reviews whether the item or service is medically necessary and covered under your benefits.
While prior authorization is intended to prevent unnecessary or wasteful spending, it can sometimes delay access to care. Studies have shown that lengthy prior authorization processes may lead some patients to abandon treatment or experience worsened health outcomes while waiting for a decision.
For years, Medicare Advantage and Part D plans have used prior authorization extensively. Original (Traditional) Medicare, by contrast, has historically required it only for a narrow set of items. That landscape is changing in 2026.
The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F)
The centerpiece of the 2026 reforms is the CMS Interoperability and Prior Authorization Final Rule, formally known as CMS-0057-F. Finalized in 2024, this rule establishes new requirements for how health plans handle prior authorization requests, with operational provisions taking effect on January 1, 2026.
The rule applies to:
- Medicare Advantage (MA) organizations
- State Medicaid and CHIP fee-for-service programs
- Medicaid managed care plans and CHIP managed care entities
- Qualified Health Plan (QHP) issuers on the Federally Facilitated Exchanges
For Medicare beneficiaries enrolled in MA or Part D plans, the practical impact is substantial.
Faster Decision Timelines
One of the most meaningful changes is the requirement for shorter prior authorization response times. Previously, Medicare Advantage plans could take up to 14 calendar days to respond to a standard prior authorization request. Under the new rule:
- Standard (non-urgent) requests: Plans must issue a decision within 7 calendar days
- Expedited (urgent) requests: Plans must issue a decision within 72 hours
These tighter timelines are designed to reduce the delays that can occur when beneficiaries are waiting for approval of a surgery, diagnostic test, specialist referral, or other service.
Specific Reasons for Denials
Beginning in 2026, if a prior authorization request is denied, the plan must provide a specific reason for the denial in plain language. This applies regardless of how the request was submitted — whether electronically, by fax, or by phone.
Previously, denial notices could be vague or difficult to interpret. The new requirement means you should receive a clear explanation of why a service was not approved, which criteria were applied, and what evidence was considered. This information can be valuable if you choose to appeal.
Transparency and Public Reporting
Impacted payers must now publicly report prior authorization metrics on their websites annually. The first set of data was due by March 31, 2026, covering the previous year's activity.
These metrics may include:
- The number of prior authorization requests received
- Approval and denial rates
- Average response times
- Appeal and overturn rates
This transparency allows beneficiaries, providers, and policymakers to compare how different plans handle prior authorization and hold plans accountable for their practices.
Electronic Prior Authorization Requirements
The rule also lays the groundwork for a shift toward fully electronic prior authorization. While the operational provisions took effect in January 2026, the technology-related requirements — including the development of standardized application programming interfaces (APIs) for electronic prior authorization — have a compliance date of January 1, 2027 for MA organizations.
Once implemented, electronic prior authorization is expected to reduce paperwork, speed up the exchange of clinical information, and make the entire process more efficient for both providers and plans.
The WISeR Model: A Prior Authorization Pilot in Six States
In a separate but related development, CMS launched the Wasteful and Inappropriate Service Reduction (WISeR) Model on January 1, 2026. This is a pilot program that introduces prior authorization into Original Medicare for the first time in a structured way, operating in six states:
- Arizona
- New Jersey
- Ohio
- Oklahoma
- Texas
- Washington
The model is scheduled to run through December 31, 2031.
How the WISeR Model Works
Under WISeR, providers and suppliers serving Original Medicare beneficiaries in the six participating states may submit a prior authorization request for select services before delivering care. Alternatively, they may proceed with the service and undergo a post-service, pre-payment review.
The program focuses on services that CMS has identified as vulnerable to fraud, waste, and abuse. The initial list includes approximately 17 categories of items and services, such as:
- Skin and tissue substitutes
- Electrical nerve stimulator implants
- Knee arthroscopy for knee osteoarthritis
- Epidural steroid injections for pain management (excluding facet-joint injections)
- Certain other procedures and durable medical equipment
Importantly, the model excludes inpatient-only services, emergency services, and any service that would pose a substantial risk to a patient if delayed.
AI and Machine Learning in the Review Process
The WISeR model is notable for its use of artificial intelligence (AI) and machine learning (ML) to assist in reviewing prior authorization requests. CMS has partnered with technology companies in each of the six states to serve as model participants:
- Cohere Health, Inc. (Texas)
- Genzeon Corporation (New Jersey)
- Humata Health, Inc. (Oklahoma)
- Innovaccer Inc. (Ohio)
- Virtix Health LLC (Washington)
- Zyter Inc. (Arizona)
These organizations use AI-assisted tools to help evaluate whether services meet Medicare coverage requirements. However, CMS has emphasized a critical safeguard: all recommendations for non-payment must be determined by appropriately licensed clinicians, not by AI alone. Technology may assist in processing and flagging requests, but a qualified human reviewer makes the final decision on any denial.
Beneficiary Protections Under WISeR
If you have Original Medicare and live in one of the six pilot states, there are several protections to be aware of:
- Your Medicare coverage does not change. The WISeR model does not alter what services are covered or your freedom to choose providers.
- Emergency services are excluded. You will never need prior authorization for emergency care under this model.
- You retain all existing appeal rights. If a prior authorization is not approved, you may follow the standard Medicare appeals process.
Gold-Carding Provisions for Providers
A promising feature expected to roll out by mid-2026 is a "gold carding" pathway within the WISeR model. Gold carding allows providers and suppliers who demonstrate consistently high approval rates and strong compliance records to be exempted from prior authorization or pre-payment review for WISeR-covered services.
Here is how it generally works:
- Medicare Administrative Contractors (MACs) review a provider's or supplier's prior authorization approval history
- Providers with approval rates at or above a specified threshold (such as 90% or higher) may qualify for an exemption
- Exempt providers can deliver covered services without submitting a prior authorization request, reducing administrative burden
- CMS conducts periodic post-payment reviews to ensure continued compliance
- Providers are notified in advance before an exemption period begins or ends
At the state level, several states have already enacted their own gold carding laws for commercial insurance. The WISeR model represents one of the first applications of this concept within Medicare.
Gold carding does not directly change anything for beneficiaries in terms of coverage, but it may result in faster access to care if your provider qualifies for the exemption.
How These Changes Affect Medicare Advantage and Part D Plans
If you are enrolled in a Medicare Advantage plan, the CMS-0057-F rule changes apply directly to your plan starting in 2026. You may notice:
- Faster responses when your provider submits a prior authorization request
- Clearer denial letters that explain exactly why a service was not approved
- Greater transparency as plans publish their prior authorization data publicly
For Part D prescription drug plans, similar principles apply when prior authorization is required for certain medications. Plans must adhere to the updated decision timelines and provide specific reasons if a drug request is denied.
The WISeR pilot program, by contrast, applies only to Original Medicare beneficiaries in the six participating states. If you have a Medicare Advantage plan, WISeR does not apply to you, though your MA plan is subject to its own prior authorization rules under CMS-0057-F.
Your Rights: How to Appeal a Prior Authorization Denial
If a prior authorization request is denied — whether under a Medicare Advantage plan or through the WISeR model — you have the right to appeal. Understanding the appeals process is important, especially since data from recent years shows that a significant majority of appealed denials are ultimately overturned.
Medicare Advantage Appeals Process
Medicare Advantage plans follow a five-level appeals process:
-
Plan Reconsideration: Contact your plan and request a reconsideration of the denial. You generally have 60 days from the date of the denial notice. For pre-service denials, the plan must respond within 30 calendar days (or 72 hours for expedited requests).
-
Independent Review Entity (IRE): If the plan upholds the denial, your case is automatically forwarded to an Independent Review Entity for an impartial review.
-
Office of Medicare Hearings and Appeals (OMHA): If the IRE upholds the denial and the amount in controversy meets the required threshold, you may request a hearing before an Administrative Law Judge.
-
Medicare Appeals Council: You may request a review by the Medicare Appeals Council if you disagree with the ALJ decision.
-
Federal District Court: As a final step, you may file a case in federal court if the amount in controversy meets the threshold.
Tips for a Successful Appeal
- Act promptly. Note the deadlines on your denial notice and file your appeal within the required timeframe.
- Request the specific reason for denial. Under the new 2026 rules, plans must provide this, which can help you and your provider address the plan's concerns directly.
- Ask your provider for supporting documentation. Medical records, clinical notes, and letters of medical necessity from your doctor can strengthen your appeal.
- Keep detailed records. Save copies of all correspondence, denial notices, and appeal submissions.
- Consider requesting an expedited appeal if your health condition requires urgent attention.
Where to Get Help
- 1-800-MEDICARE (1-800-633-4227): Call Medicare's helpline for questions about prior authorization, appeals, or your rights. TTY users can call 1-877-486-2048.
- Medicare.gov: Visit Medicare.gov for official information about coverage, claims, and appeals.
- Your State Health Insurance Assistance Program (SHIP): SHIP counselors provide free, personalized help with Medicare questions, including navigating prior authorization and appeals. You can find your local SHIP at shiphelp.org or by calling 1-800-MEDICARE.
What You Should Do Now
While these regulatory changes are largely implemented by health plans and providers, there are a few steps you can take to stay informed:
- Know whether you are affected by the WISeR pilot. If you have Original Medicare and live in Arizona, New Jersey, Ohio, Oklahoma, Texas, or Washington, your provider may need to obtain prior authorization for certain services starting in 2026.
- Review your plan's prior authorization requirements. Whether you have Medicare Advantage or a Part D plan, check your plan's Evidence of Coverage document for details on which services and drugs require prior authorization.
- Understand your appeal rights. If a prior authorization request is denied, you are not required to accept the decision. The appeals process exists to protect your access to medically necessary care.
- Ask questions. If you are unsure whether a service requires prior authorization, or if you receive a denial that you do not understand, contact your plan directly or reach out to SHIP for free assistance.
Looking Ahead
The 2026 prior authorization reforms represent a meaningful step toward reducing administrative barriers in Medicare. The shorter decision timelines, transparency requirements, and specific denial reason mandates under CMS-0057-F are designed to improve the experience for both beneficiaries and providers. The WISeR pilot program, while limited to six states and select services, is testing whether technology-assisted prior authorization can reduce waste while preserving timely access to care.
Additional provisions are on the horizon. Electronic prior authorization API requirements take effect in January 2027, and the gold carding pathway within WISeR is expected to expand as the model matures. CMS has indicated it will monitor outcomes closely and adjust the program as needed.
For now, the most important thing you can do is stay informed about how these changes affect your specific coverage situation — and know that help is available if you need it.